Current Portfolio
SNIPR Biome
SNIPR Biome is a biotechnology company developing CRISPR-based medicines that selectively target disease-causing bacteria in the microbiome. Its programs aim to treat infections, prevent antimicrobial resistance, and enable safer advanced therapies.
Key Facts
- Sector
Life Sciences
- Country
Denmark
- Fund
LSP 6
- Entry
2019
- EQT Responsible Advisor
Daniela Begolo
- Website
- https://www.sniprbiome.com/
News
Do You Want to Know More?
We are eager to explore how we can achieve great things together.